A notebook is excellent at capture. Write down a sale, log a delivery, note today’s stock count, and it’s all there, reliable and easy to check. That’s exactly why so many owners trust it.
But a notebook is terrible at pattern. It can tell you what happened today if you flip to that page. It can’t tell you what’s been happening over the last three weeks, because that requires holding dozens of entries in your head at once and comparing them against each other. No one does that reliably while also running a business.
Where Pharmacy Stock Losses Actually Come From
Here’s where that gap actually costs money. Most pharmacy stock losses fall into four categories, and every one of them is a visibility problem, not a discipline problem.
Reorder timing. With paper, restocking is usually reactive. You notice a shelf is empty after it’s empty, or a customer asks for something you don’t have. What paper can’t show you is the pattern underneath: that a particular antibiotic runs out every three weeks, or that cough syrup demand spikes every school term. That’s not one data point. It’s a trend across time, invisible in a notebook and obvious the moment something is actually tracking it.
Shrinkage and unexplained loss. A notebook records a sale when someone remembers to write it down. It can’t compare what you bought against what you sold against what’s actually on the shelf, and flag the gap. That gap, whether it’s theft, spoilage, or a mistake, is one of the most common sources of pharmacy stock losses, and it usually gets discovered by accident, months later, as one large uncomfortable surprise during a physical count. Continuous tracking turns that yearly shock into a small monthly signal you can act on early.
Expiry exposure. The expiry date is written somewhere in your book, if you go looking for it. But paper won’t proactively tell you that forty units expire in three weeks and you still have half your stock sitting there. That check requires scanning every entry against today’s date, across hundreds of products, by hand. Losing stock to expiry is one of the most direct losses a pharmacy has, and it’s almost entirely a visibility failure, not a discipline one.
Seasonality and demand shifts. Malaria drugs spike in the rainy season. Allergy medication spikes at certain times of year. Certain products move around payday. You might sense this vaguely, but paper can’t confirm it or tell you by how much, so you either overstock (cash tied up on the shelf) or understock (lost sales at the counter) instead of ordering against an actual pattern.
None of this means your notebook is bad at record keeping. It’s fine at that job, which is exactly why you trust it. The honest point is that record keeping and pattern visibility are two different jobs, and paper was only ever built for the first one.
That’s the job phAMACore Cloud is built for. Not to replace your instincts, but to watch the pattern you don’t have time to watch yourself, so pharmacy stock losses from stockouts, expiries, and shrinkage show up before they cost you. If you want a fuller breakdown of how the platform tracks this, our stock and inventory module covers it in more depth.
For context on how big this problem is industry-wide, the Pharmacy and Poisons Board publishes guidance on stock accountability that most of this loss traces back to.
Curious what that would actually look like for your pharmacy? Reply with “pharmacy notebook guide” to this email, sales@corebase.co.ke , and we’ll walk you through it.
